openPR Logo
Press release

D-dimer Testing Market Analysis & Trends 2022

11-15-2017 10:56 AM CET | Health & Medicine

Press release from: TMR - Research Reports

According to the research report, the global market for D-dimer testing stood at US$1.5 bn in 2013. Analysts project this market to rise at a CAGR of 2.60% between 2014 and 2022 and increase to US$1.9 bn by the end of the forecast period. D-dimer testing is majorly applied in deep vein thrombosis, disseminated intravascular coagulation, and pulmonary embolism. Among testing methods, the demand for laboratory D-dimer tests is greater than other types of D-dimer tests. The trend is anticipated to remain so over the period of the forecast. Geographically, North America, closely followed by Europe, leads the global market for D-dimer testing, thanks to the rising research activities to enhance specificities of D-dimer tests in an effort to detect any coagulation disease in the patient. Researchers anticipate this regional market to continue on the top over the forthcoming years, reports the research study.

Read Report Overview @ https://www.transparencymarketresearch.com/d-dimer-market.html

“The increasing number of patients asking for coagulation testing is boosting the global D-dimer testing market substantially,” states a TMR analyst. A number of technological advancements, such as the incorporation of highly sensitive and specified hemostasis markers for various automated instruments, and the continual observation of patients on anti-coagulation therapy are also propelling this market substantially.

Over the coming years, the support from various government across the world, in terms of funds for research and development and awareness programs intended to encourage early diagnosis of coagulation diseases, is likely to drive the growth of this market substantially in the near future, states the research report.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2398

On the other hand, the difficulties faced during the interpretation of D-dimer levels in the geriatrics population pose a serious challenge for the growth of this market. The regular fluctuation in the level of thrombosis in elderly people, proving D-dimer test less useful in excluding pulmonary embolism or deep vein thrombosis, is one of the main factor behind this. The clinical adoption of point-of-care D-dimer tests in hospitals and physicians’ clinics is also expected to slow down the market’s growth in the years to come, reports the research study.

The global D-dimer testing market looks highly fragmented due to the presence of a large number of vendors providing kits, instruments, and regents, states a new research report by Transparency Market Research (TMR). Hitherto, the players operating in this market have been relying heavily on innovation and technological advancements for the growth of their businesses. However, they are likely to turn to mergers and acquisitions in the near future for further expansion, notes the research study. Some of the key players mentioned in this report are Abbott Laboratories, Becton, Dickinson and Co., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific.

Buy Full D-dimer Testing Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2398<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release D-dimer Testing Market Analysis & Trends 2022 here

News-ID: 817778 • Views: 196

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for US$1

$1 Billion Glamping Market Creates New Wave in the US - Market Research by Arizt …
Arizton’s latest research report states that the glamping market in US is projected to reach a revenue of around $1 billion by 2024, growing at a CAGR of over 15% during 2018−2024. Key Highlights Offered in the Report: • The number of camping households reached 80 million in the US market, hence campers are moving towards glamping activities with luxurious amenities. • Relaxation and de-stressing are the main motives behind the popularity of
Elemental Fluorine Market Will Reach US$ 1 Bn by 2026
Demand for active chemical agents such as elemental fluorine continues to surge on the account of rampant industrialization spanning across the globe. Technological developments have made production of pure fluorine gas more feasible than before. Intensive research on the compatibility of elemental fluorine with other matter has aided in formulation of advanced electronegative compounds, which have greater industrial applicability. Persistence Market Research recently published its study on the global market
Elemental Fluorine Market Will Reach US$ 1 Bn by 2026
Demand for active chemical agents such as elemental fluorine continues to surge on the account of rampant industrialization spanning across the globe. Technological developments have made production of pure fluorine gas more feasible than before. Intensive research on the compatibility of elemental fluorine with other matter has aided in formulation of advanced electronegative compounds, which have greater industrial applicability. Persistence Market Research recently published its study on the global market
Pressure Guidewires Market to Exceed US$ 1 Bn in 2024
Increasing healthcare expenditure on treatment of cardiovascular diseases continues to propel the demand for pressure guidewires in the world. Cardiovascular treatment procedures developed over the years have integrated the use of pressure guidewires for navigating through blood vessels or lesions. The instrumental contribution of pressure guidewire as a medical device in assisting the highly-intrinsic cardiovascular surgeries, coupled with the rising preference to angioplasty, helps it gain surplus demand from all
Global Permeate Market Reach US$ 1 Bn by 2027
The global permeate market is likely to grow at a moderate pace during the forecast period 2017-2027 according to a new study added to Market Research Reports Search Engine (MRRSE). The report titled “Permeate Market: Animal Feed Anticipated to be the Most Attractive Application Segment during the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 – 2027” offers in-depth analysis and insights on the global permeate
Pressure Guidewire Market Stood at US$ 1 Billion by 2024
According to Persistence Market Research, the global pressure guidewire market will witness significant contribution from Koninklijke Philips N.V. (Volcano Corporation) and Abbott Laboratories (St. Jude Medical, Inc.) – global industry leaders in medical device manufacturing. While these two players are expected to account for nearly two-third of global pressure guidewire revenues, the market will also see considerable involvement of North American companies Opsens, Inc. (Canada) and Boston Scientific Corporation (US).